Pharmacotherapy of Borderline Personality Disorder
- 1 February 1988
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 45 (2) , 111-119
- https://doi.org/10.1001/archpsyc.1988.01800260015002
Abstract
From JAMA Psychiatry — Pharmacotherapy of Borderline Personality Disorder — Alprazolam, Carbamazepine, Trifluoperazine, and TranylcypromineThis publication has 38 references indexed in Scilit:
- Symptoms and EEG Findings in the Borderline SyndromeThe International Journal of Psychiatry in Medicine, 1986
- Borderline and Schizotypal Personality Disorders Treated With Low-Dose Thiothixene vs PlaceboArchives of General Psychiatry, 1986
- Alprazolam vs Amitriptyline in Depressions With Reduced REM LatenciesArchives of General Psychiatry, 1985
- Depression and panic in patients with borderline personality disorderBiological Psychiatry, 1985
- Depression in borderline patients: A prospective EEG sleep studyPsychiatry Research, 1985
- CARBAMAZEPINE FOR UNCONTROLLED RAGE OUTBURSTSThe Lancet, 1984
- Dexamethasone Suppression Test in Hospitalized Depressed Patients with Borderline Personality DisorderJournal of Nervous & Mental Disease, 1984
- The dexamethasone suppression and thyrotropin-releasing hormone tests in depressed borderline patientsPsychoneuroendocrinology, 1983
- Effect of preexisting borderline personality disorder on clinical and EEG sleep correlates of depressionPsychiatry Research, 1983
- The TRH test in patients with borderline personality disorderPsychiatry Research, 1983